SCHOTT Pharma, a pharma drug containment solutions and delivery systems provider, developed a new nest design for prefillable polymer syringes, which holds a total of 160 syringes without changing the size of the nest. This marks an increase of 60% compared to the standard nest that fits 100 syringes. 
 
In the same cycle time, the new nest enables pharma companies to fill significantly more syringes per hour than the nest with 100 syringes. As a result, pharma companies can increase their efficiency by up to 67% while significantly reducing their manufacturing costs and reducing the product carbon footprint (PCF) by 17%, according to the company.
 
“Through this step, we are actively addressing one of the main levers to improve the costs of pharma companies and reorganizing their value chain,” said Andreas Reisse, CEO of SCHOTT Pharma. “This innovation is a testament to our engineering expertise and with it, we’re enabling pharma manufacturers to meet their needs for efficiency, sustainability, and compliance, while assuring uncompromised quality. We have received positive feedback from the market so far and first customers are already planning to implement the new product.”